Experimental Alzheimer's Drug, Donanemab, Slows Thinking Declines in Late-Stage Trial

MONDAY, July 17, 2023 -- Another experimental drug meant to slow the damage of Alzheimer’s appears poised to join a growing arsenal of new treatments for this memory-robbing disease.
In research published online Monday in the Journal of the...